UWP
ABBV icon

Uniting Wealth Partners’s AbbVie ABBV Stock Holding History

Uniting Wealth Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$679K Buy
2,700
+87
+3% +$18.7K 0.14% 100
2026
Q1 		$568K Buy
2,613
+1
+0% +$222 0.12% 103
2025
Q4 		$597K Buy
2,612
+673
+35% +$153K 0.18% 71
2025
Q3 		$449K Buy
+1,939
New +$395K 0.11% 106

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Uniting Wealth Partners's ABBV Position: Q2 2026 in Review

Uniting Wealth Partners increased its AbbVie (ABBV) stake by 3.3% in Q2 2026, buying an estimated $18.7K and bringing the position to 2,700 shares worth $679K. The position accounts for 0.14% of the portfolio, ranked #100.

Uniting Wealth Partners first reported a position in ABBV in Q3 2025 and has held it in 4 quarters since. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Uniting Wealth Partners held 2,700 shares of AbbVie worth $679K as of Q2 2026.
  • Uniting Wealth Partners bought 87 AbbVie shares in Q2 2026, an estimated $18.7K.
  • AbbVie made up 0.14% of Uniting Wealth Partners's portfolio in Q2 2026, its #100 holding.
  • Uniting Wealth Partners first reported a position in AbbVie in Q3 2025 and has held it in 4 quarters since.
  • 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Uniting Wealth Partners's 13F filing for Q2 2026, filed 6 Aug 2026.